Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.70 USD
0.00 (0.00%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $1.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.70 USD
0.00 (0.00%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $1.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Zacks News
Tilray (TLRY) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports fourth-quarter 2020 results.
Marijuana ETFs on a High on Reddit Frenzy
by Sanghamitra Saha
After promoting GameStop (GME) and Silver, Reddit's discussion has now popularized marijuana stocks like Sundial Growers (up 78.8% on Feb 10) and Tilray (up more than 50% on Feb 10).
Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Meridian Bioscience, CRISPR Therapeutics, Tilray and Uber highlighted as Zacks Bull and Bear of the Day
3 Stocks to Benefit From the Rapid Adoption of Marijuana
by Zacks Equity Research
The marijuana industry looks set to witness growth going forward due to wider adoption, making it prudent to look at names like Scotts Miracle-Gro (SMG), GrowGeneration (GRWG) and Tilray (TLRY)
Tilray Bought by the Reddit Crowd, Plus UBER's Q3
by Mark Vickery
Shares of the marijuana pharma company shot up another 51% Wednesday, following a +44% performance yesterday; Tilray is now up 400% in just the last month alone.
Cannabis Stocks Rise on Hopes of Federal Legalization in US
by Zacks Equity Research
Cannabis stocks seem poised to gain on hopes of removal of the federal ban on cannabis products under the new administration.
The Zacks Analyst Blog Highlights: Canopy Growth, Tilray, Cisco Systems, Twitter and Lyft
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Canopy Growth, Tilray, Cisco Systems, Twitter and Lyft
Pot Stocks Take Markets Higher; Plus Beats for Cisco, Twitter, Lyft
by Mark Vickery
With Tilray (TLRY) +44% and Canopy (CGC) +12% on the day, the Nasdaq and Russell 2000 managed to climb to fresh all-time highs Tuesday.
Cannabis ETFs Spike on Jazz-GW Pharma Deal
by Sweta Killa
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.
Cannabis ETF Tops in January: 5 Stocks That Led the Way
by Sweta Killa
Inside the top performing stocks in the top ETF of January.
Sunoco, Lemonade, Tilray, Innovative Industrial Properties and Square highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Sunoco, Lemonade, Tilray, Innovative Industrial Properties and Square highlighted as Zacks Bull and Bear of the Day
3 Marijuana Stocks to Play the Green Rush in 2021
by Tirthankar Chakraborty
Marijuana stocks are set to be the rage on Wall Street in hopes of legalization in and around the United States, which calls for keeping an eye on the likes of Tilray (TLRY) and Square (SQ).
Is Tilray (TLRY) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (TLRY) Outperforming Other Medical Stocks This Year?
The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, JPMorgan, Beazer Homes USA, Tesla and Tilray
Here're the 5 Top Stock Trades for 2021
by Tirthankar Chakraborty
We have highlighted stocks worth a look from the five best trading areas of the current year. This includes NVIDIA (NVDA), JPMorgan Chase (JPM), Beazer Homes (BZH), Tesla (TSLA) and Tilray (TLRY).
Tilray (KL) Looks Good: Stock Adds 5.3% in Session
by Zacks Equity Research
Tilray (KL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Is the Options Market Predicting a Spike in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
ETFs to Buy as Tilray-Aphria Merger Creates Cannabis Giant
by Sweta Killa
Investors seeking to take advantage of the merger deal between Tilray and Aphria could invest in any of the cannabis ETFs.
Company News for Dec 17, 2020
by Zacks Equity Research
Companies In The News Are: GOOGL, LUV, TLRY, APHA, GLPG, GILD.
Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Is a Disappointment in Store for Tilray's (TLRY) Q3 Earnings?
by Zacks Equity Research
Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports third-quarter 2020 results.
Implied Volatility Surging for Tilray (TLRY) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Do Options Traders Know Something About Tilray (TLRY) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.
Tilray, Inc. (TLRY) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Tilray, Inc. (TLRY) delivered earnings and revenue surprises of 3.70% and -8.87%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?